 |
Katharine Briggs
Katharine is a postdoctoral researcher in lab of Dr. Bruce Yu at the University of Maryland. She received her Ph.D. from the University of Maryland, College Park. Her research investigates whether current methods are sufficient for detecting differences between innovator and generic complex drugs (e.g., nanomedicines). Her fellowship is supported by MedImmune.
|
 |
Dong Guo
Dong is a postdoctoral fellow in pharmaceutical sciences at the University of Maryland. She received her medical degree and PhD degree in clinical pharmacology from Central South University, China. She has extensive research experience in cellular and molecular biology, genetics, pharmacology, and toxicology. Her current project investigates genetic basis of drug response and transporter-mediated drug-drug interaction. Her mentor is Dr. Yan Shu. Her fellowship is supported by Optivia Biotechnology Company.
|
 |
Savyasachi Shah
Savyasachi is a postdoctoral research fellow in Pharmacoeconomics in the Department of Pharmaceutical Health Services Research. He holds a BDS and a MPH from the Johns Hopkins Bloomberg School of Public Health. His current research focuses on comparative effectiveness research, and on evaluating prescription drug misuse prevention strategies and developing methods to assess the value of drugs and devices post-marketing. He is advised by Dr. Fadia Tohme Shaya.
|
 |
Mingming Yu
Mingming is a post-doctoral fellow in pharmaceutical sciences at the University of Maryland. He received a Ph.D. degree in pharmaceutical sciences from Ocean University of China. His project is focused on LC-MS/MS method development and validation, clinical sample analysis, and pharmacokinetic data analysis. His advisors are Dr. Hazem Hassan and Dr. Audra Stinchcomb.
|
